A mathematical model of the treatment and survival of patients with high-grade brain tumours

Journal of Theoretical Biology

Volumn 245, Issue 1, 2007, Pages 112-124

  Kirkby, Norman F ^a   Jefferies, Sarah J ^b   Jena, Raj ^b,c   Burnet, Neil G ^b,c  

^a UNIVERSITY OF SURREY   (United Kingdom)

^b ADDENBROOKE S HOSPITAL   (United Kingdom)

^c UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Brain cancer; Glioblastoma; Patient survival; Radiotherapy; Tumour growth

Indexed keywords

BRAIN; CANCER; DISEASE TREATMENT; MONTE CARLO ANALYSIS; NUMERICAL MODEL; PREDICTION; RADIATION EXPOSURE; SURVIVAL; TUMOR;

AGE DISTRIBUTION; ARTICLE; BRAIN DAMAGE; BRAIN DEATH; BRAIN TUMOR; CANCER GRADING; CANCER RADIOTHERAPY; CANCER SURVIVAL; CANCER SURVIVOR; CHEMICAL ENGINEERING; CHEMICAL REACTION; CLINICAL STUDY; HYPOXIA; MATHEMATICAL MODEL; MEDICAL DECISION MAKING; MEDICAL INFORMATION; MONTE CARLO METHOD; OUTCOME ASSESSMENT; PHENOMENOLOGY; PREDICTION; PRIORITY JOURNAL; RADIATION DOSE; RADIOSENSITIVITY; STATISTICAL DISTRIBUTION; THERAPY EFFECT; TREATMENT PLANNING; TUMOR GROWTH;

AGE DISTRIBUTION; BRAIN; BRAIN NEOPLASMS; GLIOBLASTOMA; HUMANS; MATHEMATICS; MODELS, BIOLOGICAL; MONTE CARLO METHOD; SURVIVAL ANALYSIS; TIME FACTORS;

EID: 33846782929     PISSN: 00225193     EISSN: 10958541     Source Type: Journal    
DOI: 10.1016/j.jtbi.2006.09.007     Document Type: Article

References (31)

1. Alarcon T., Byrne H.M., and Maini P.K. A cellular automaton model for tumour growth in inhomogeneous environment. J. Theor. Biol. 225 2 (2003) 257-274
2. Alarcon T., Byrne H.M., and Maini P.K. A multiple scale model for tumor growth. Multiscale Model. Simul. 3 2 (2005) 440-475
3. Antipas V.P., Stamatakos G.S., Uzunoglu N.K., Dionysiou D.D., and Dale R.G. A spatio-temporal simulation model of the response of solid tumours to radiotherapy in vivo: parametric validation concerning oxygen enhancement ratio and cell cycle duration. Phys. Med. Biol. 49 8 (2004) 1485-1504
4. Bjork-Eriksson T., West C.M., Karlsson E., Slevin N.J., Davidson S.E., James R.D., and Mercke C. The in vitro radiosensitivity of human head and neck cancers. Br. J. Cancer 77 12 (1998) 2371-2375
5. Burnet N.G., Jefferies S.J., Benson R.J., Hunt D.P., and Treasure F.P. Years of life lost (YLL) from cancer is an important measure of population burden-and should be considered when allocating research funds. Br. J. Cancer 92 (2005) 241-245
6. Burnet N.G., Jena R., Jefferies S.J., Stenning S.P., and Kirkby N.F. Mathematical modelling of survival of glioblastoma patients suggests a role for radiotherapy dose escalation and predicts poorer outcome following delay to start treatment. Clin. Oncol. 18 2 (2006) 93-103
7. Byrne H.M., and Chaplain M.A. Mathematical models for tumour angiogenesis: numerical simulations and non-linear wave solutions. Bull. Math. Biol. 57 3 (1995) 461-486
8. Chaplain M.A. Mathematical modelling of angiogenesis. J. Neurooncol. 50 1-2 (2000) 37-51
9. Deacon J., Peckham M.J., and Steel G.G. The radioresponsiveness of human tumours and the initial slope of the cell survival curve. Radiother. Oncol. 2 4 (1984) 317-323 (Review)
10. Dionysiou D.D., Stamatakos G.S., Uzunoglu N.K., Nikita K.S., and Marioli A. A four-dimensional simulation model of tumour response to radiotherapy in vivo: parametric validation considering radio sensitivity, genetic profile and fractionation. J. Theor. Biol. 230 1 (2004) 1-20
11. Frank S., Müller J., Bonk C., Haroske G., Schackert H.K., and Schackert G. Transmission of glioblastoma multiforme through liver transplantation. Lancet 352 9121 (1998) 31
12. Jena R., Price S.J., Baker C., Jefferies S.J., Pickard J.D., Gillard J.H., and Burnet N.G. Diffusion tensor imaging: possible implications for radiotherapy treatment planning of patients with high grade glioma. Clin. Oncol. 17 8 (2005) 581-590
13. Kaplan E.L., and Meier P. Nonparametric estimation from incomplete observations. J. Am. Statist. Assoc. 53 (1958) 457-481
14. Kirkby N.F., Burnet N.G., and Faraday D.B.F. Mathematical modelling of the response of tumour cells to radiotherapy. Nucl. Instrum. Methods: Phys. Res. B 188 (2002) 210-215
15. Kirkby N.F., Faraday D.B.F., Short S.C., Woodcock M., Joiner M.C., and Burnet N.G. Mathematical modelling to develop a novel radiotherapy schedule for high-grade brain tumours, based on phase distribution of low-dose hypersensitivity in human glioma cell lines. Radiother. Oncol. 64 Suppl. 1 (2002) S57
16. Kirkby N.F., Jena R., Jefferies S.J., Stenning S.P., and Burnet N.G. Monte Carlo modelling as an aid to clinical trial design: examples from glioblastoma. Clin. Oncol. 17 Suppl. 1 (2005) S18
17. Levine H.A., Sleeman B.D., and Nilsen-Hamilton M. Mathematical modeling of the onset of capillary formation initiating angiogenesis. J. Math Biol. 42 3 (2001) 195-238
18. Murray J.D. Growth and control of brain tumours. Mathematical Biology II: Spatial and Biomedical Applications. third ed (2003), Springer, New York 536-613
19. Old S.E., Burnet N.G., and Waite K.J. Transmission of tumours by liver transplantation. Lancet 352 9130 (1998) 822
20. Peacock J., Ashton A., Bliss J., Bush C., Eady J., Jackson C., Owen R., Regan J., and Yarnold J. Cellular radiosensitivity and complication risk after curative radiotherapy. Radiother. Oncol. 55 2 (2000) 173-178
21. Press W.H., Tenkolsky S.A., Vetterling W.T., and Flannery B.P. Fortran Numerical Recipes in Fortran 90 (1996), Cambridge University Press, Cambridge
22. 2 distribution and bioreductive enzymes in human malignant brain tumors. Int. J. Radiat. Oncol. Biol. Phys. 29 3 (1994) 427-431
23. Saunders M., Dische S., Barrett A., Harvey A., Gibson D., and Parmar M. Continuous hyperfractionated accelerated radiotherapy (CHART) versus conventional radiotherapy in non-small-cell lung cancer: a randomized multi-centre trial. Lancet 350 (1997) 161-165
24. SBU-The Swedish Council on Health Technology Assessment. Radiotherapy for cancer. Acta Oncol. Suppl. 6 (1996)
25. Silverman, B.W., 1998. Density estimation for statistics and data analysis. Monographs on Statistics and Applied Probability 26. Chapman & Hall/CRC, Boca Raton, FL, USA. ISBN:0-412-24620-1.
26. Stupp R., Mason W.P., van den Bent M.J., Weller M., Fisher B., Taphoorn M.J., Belanger K., Brandes A.A., Marosi C., Bogdahn U., Curschmann J., Janzer R.C., Ludwin S.K., Gorlia T., Allgeier A., Lacombe D., Cairncross J.G., Eisenhauer E., Mirimanoff R.O., and European Organisation for Research and Treatment of Cancer Brain Tumor and Radiotherapy Groups; National Cancer Institute of Canada Clinical Trials Group. Radiotherapy plus concomitant and adjuvant temozolomide for glioblastoma. N. Engl. J. Med. 352 10 (2005) 987-996
27. Swanson K.R., Alvord Jr. E.C., and Murray J.D. Virtual brain tumours (gliomas) enhance the reality of medical imaging and highlight inadequacies of current therapy. Br. J. Cancer 86 (2002) 14-18
28. Taghian A., Ramsay J., Allalunis-Turner J., Budach W., Gioioso D., Pardo F., Okunieff P., Bleehen N., Urtasun R., and Suit H. Intrinsic radiation sensitivity may not be the major determinant of the poor clinical outcome of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 25 2 (1993) 243-249
29. Taghian A., DuBois W., Budach W., Baumann M., Freeman J., and Suit H. In vivo radiation sensitivity of glioblastoma multiforme. Int. J. Radiat. Oncol. Biol. Phys. 32 1 (1995) 99-104
30. Waite K.J., Wharton S.B., Old S.E., and Burnet N.G. Systemic metastases of glioblastoma multiforme. Clin. Oncol. 11 3 (1999) 205-207
31. West C.M., Davidson S.E., Roberts S.A., and Hunter R.D. Intrinsic radiosensitivity and prediction of patient response to radiotherapy for carcinoma of the cervix. Br. J. Cancer 68 4 (1993) 819-823